iGenis views its product development and regulatory capabilities as a vital component of its business strategy that will provide the company with a sustainable, long-term competitive advantage in the generic pharmaceuticals market.

The Company’s focus is mainly on the development of ANDAs of oral, injectable and dermatologic products for the regulated markets.

2007 iGenis Pharma, Inc. All rights reserved.